[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BE859277A - Solution injectable de l-pyroglutamyl-l-histidyl-l-prolinamide et sa preparation - Google Patents

Solution injectable de l-pyroglutamyl-l-histidyl-l-prolinamide et sa preparation

Info

Publication number
BE859277A
BE859277A BE181375A BE181375A BE859277A BE 859277 A BE859277 A BE 859277A BE 181375 A BE181375 A BE 181375A BE 181375 A BE181375 A BE 181375A BE 859277 A BE859277 A BE 859277A
Authority
BE
Belgium
Prior art keywords
pyroglutamyl
prolinamide
histidyl
preparation
injectable solution
Prior art date
Application number
BE181375A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of BE859277A publication Critical patent/BE859277A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/066—TRH, thyroliberin, thyrotropin releasing hormone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BE181375A 1976-10-01 1977-09-30 Solution injectable de l-pyroglutamyl-l-histidyl-l-prolinamide et sa preparation BE859277A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51118875A JPS5920647B2 (ja) 1976-10-01 1976-10-01 注射剤

Publications (1)

Publication Number Publication Date
BE859277A true BE859277A (fr) 1978-03-30

Family

ID=14747271

Family Applications (1)

Application Number Title Priority Date Filing Date
BE181375A BE859277A (fr) 1976-10-01 1977-09-30 Solution injectable de l-pyroglutamyl-l-histidyl-l-prolinamide et sa preparation

Country Status (11)

Country Link
US (1) US4167563A (fr)
JP (1) JPS5920647B2 (fr)
AU (1) AU509037B2 (fr)
BE (1) BE859277A (fr)
CA (1) CA1092024A (fr)
DE (1) DE2743586C2 (fr)
FR (1) FR2366019A1 (fr)
GB (1) GB1592336A (fr)
HK (1) HK27884A (fr)
MY (1) MY8500267A (fr)
NL (1) NL188928C (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58167516A (ja) * 1982-03-29 1983-10-03 Daigo Eiyou Kagaku Kk 糖、アミノ酸、電解質輸液の製造法
US4493828A (en) * 1982-07-26 1985-01-15 Merck & Co., Inc. Use of thyrotropin releasing hormone and related peptides as poultry growth promotants
JPS60190711A (ja) * 1984-03-09 1985-09-28 Tokyo Tanabe Co Ltd プロトポルフイリン類注射用製剤
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
WO1996008265A1 (fr) * 1994-09-12 1996-03-21 The Trustees Of The University Of Pennsylvania Facteur inhibiteur de liberation de la corticotropine et procedes d'utilisation
AU2001276737A1 (en) * 2000-08-04 2002-02-18 Chugai Seiyaku Kabushiki Kaisha Protein injection preparations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266415C (fr) *
JPS5121050B1 (fr) 1962-04-07 1976-06-30
GB1062898A (en) * 1963-06-14 1967-03-22 Evans Medical Ltd Pharmaceutical compositions containing protamines
IL30448A (en) * 1967-08-02 1972-06-28 Diagnostic Data Inc Protein metal chelate composition stabilized with saccharide,and preparation thereof
FR2221127A2 (en) * 1973-03-13 1974-10-11 Fabre Sa Pierre Corticoid or pyrazolone compsns. - contg. a natural polyol-free from Cerogenic activity
FR2221128A2 (en) * 1973-03-13 1974-10-11 Fabre Sa Pierre Aspirin - polyol compsns. - contg. inositol, ribitol or glucuronic acid - free from ulcerogenic activity
US3865934A (en) * 1973-04-02 1975-02-11 Abbott Lab Method of enhancing memory and learning
US3873709A (en) * 1974-02-19 1975-03-25 Abbott Lab Method of treating psychosis
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
JPS51118841A (en) * 1975-04-03 1976-10-19 Takeda Chem Ind Ltd A drug for improving and treating clouding of consciousness

Also Published As

Publication number Publication date
DE2743586C2 (de) 1987-01-29
NL7710693A (nl) 1978-04-04
NL188928C (nl) 1992-11-16
FR2366019A1 (fr) 1978-04-28
US4167563A (en) 1979-09-11
NL188928B (nl) 1992-06-16
JPS5344616A (en) 1978-04-21
HK27884A (en) 1984-03-30
AU509037B2 (en) 1980-04-17
GB1592336A (en) 1981-07-08
FR2366019B1 (fr) 1981-02-06
JPS5920647B2 (ja) 1984-05-15
DE2743586A1 (de) 1978-04-06
MY8500267A (en) 1985-12-31
AU2907177A (en) 1979-03-29
CA1092024A (fr) 1980-12-23

Similar Documents

Publication Publication Date Title
FR2316201A1 (fr) Similigranite et sa preparation
SE426652B (sv) Spruta
DK364277A (da) Allergenholdige substanser
BE863771A (fr) Esterastine et sa production
BE825631A (fr) Structure de mur-rideau
DK150477A (da) Kanyle
FR2343870A2 (fr) Structure de mur-rideau
IT1084082B (it) Polieterpolioli e procedimento per produrli
IT1156737B (it) Composti imidazoazinici ed imidazodiazinici
FI780239A (fi) Med boejliga tryckplattor foersedd formcylinder foer rotationstryckmaskiner
BE871702A (fr) Isochromanes, isothiochromanes, 2-benzoxepines et 2-benzothiepines
TR21418A (tr) Akarisid maddeler
BE859277A (fr) Solution injectable de l-pyroglutamyl-l-histidyl-l-prolinamide et sa preparation
BE859221A (fr) Bis-carbamoylsulfures n-substitues et leur preparation
IT1083174B (it) Triammine cicloalifatiche e procedimento per produrle
BE850552A (fr) 2-furanones et leur preparation
SE7810509L (sv) Sjelvgenomtrengande och sjelvgengande skruv
BE850936A (fr) Hydroxyquinoleines et leur preparation
TR19891A (tr) Ensektisid ve akarisid maddeler
ATA645377A (de) Drehkreuz
JPS5198670A (ja) Katsuseichitsusonyoru nox nobunkaiho
SE7605061L (sv) Vermeflekt med axialblester
BE839314R (fr) Structure de mur-rideau
IT1099526B (it) Beta-naftilfenileteri e beta-tetraidronaftilfenileteri
DK547176A (da) Sprojteferdige injicerbare oplosninger

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: TAKEDA CHEMICAL INDUSTRIES LTD

Effective date: 19970930